Barclays’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Buy |
23,174
+22,015
| +1,899% | +$164K | ﹤0.01% | 3620 |
|
|
2025
Q1 | $11K | Buy |
1,159
+15
| +1% | +$142 | ﹤0.01% | 4133 |
|
|
2024
Q4 | $6K | Hold |
1,144
| – | – | ﹤0.01% | 4236 |
|
|
2024
Q3 | $7K | Sell |
1,144
-7,126
| -86% | -$43.6K | ﹤0.01% | 4168 |
|
|
2024
Q2 | $53K | Sell |
8,270
-2,023
| -20% | -$13K | ﹤0.01% | 3652 |
|
|
2024
Q1 | $84K | Buy |
10,293
+39
| +0.4% | +$318 | ﹤0.01% | 3701 |
|
|
2023
Q4 | $86K | Buy |
10,254
+8,865
| +638% | +$74.4K | ﹤0.01% | 3746 |
|
|
2023
Q3 | $18K | Buy |
1,389
+18
| +1% | +$233 | ﹤0.01% | 3928 |
|
|
2023
Q2 | $22K | Buy |
+1,371
| New | +$22K | ﹤0.01% | 3953 |
|